Prevalence and Determinants of Poststroke Fatigue in Patients Treated With Acute Revascularization Therapy
Acta Neurologica Scandinavica · 2026-01 · 2026 (1)
DOI: 10.1155/ane/1432436 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Neurologica Scandinavica, online erschienen am 07.08.2026. Verfasst von Ramen Munir Baloch und 1 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
Fatigue adversely affects quality of life after stroke. This study is aimed at assessing the prevalence of poststroke fatigue at 6 months and its determinants in patients with acute ischemic stroke treated with revascularization therapy.
Methods
Consecutive ischemic stroke patients treated with intravenous thrombolysis and/or mechanical thrombectomy were enrolled. Sociodemographic, clinical, and ischemic lesion characteristics were collected at baseline. Fatigue was assessed at 6‐month follow‐up using the Fatigue Severity Scale (FSS), along with functional outcome, anxiety, and depression. Factors associated with poststroke fatigue were evaluated in the overall cohort and in patients with supratentorial hemispheric stroke using logistic regression models.
Results
Among 900 enrolled patients, 413 survivors had available fatigue assessment (mean age: 69.2 ± 14.1 years, 52.3% men, median NIHSS score: 9 [IQR: 5–15]). Poststroke fatigue (FSS score ≥ 36) was observed in 161 patients (39%). In the overall cohort, fatigue was independently associated with depression (OR = 5.78, 95% CI: 2.68–12.4) and anxiety (OR = 2.90, 95% CI: 1.52–5.51), whereas being single was negatively associated with fatigue (OR = 0.30, 95% CI: 0.09–0.99). A marginal association was observed with cerebellar stroke location (OR = 11.0, 95% CI: 0.88–137.6). In patients with supratentorial hemispheric stroke, fatigue was independently associated with hypertension (OR = 2.25, 95% CI: 1.13–4.47), right‐sided lesion (OR = 2.08, 95% CI: 1.13–3.83), depression (OR = 5.35, 95% CI: 2.08–13.7), and anxiety (OR = 3.10, 95% CI: 1.42–6.74).
Conclusions
Poststroke fatigue remains a frequent and clinically meaningful outcome in patients with ischemic stroke treated with revascularization therapy and is strongly associated with psychological factors and right hemispheric location. Whether specific therapeutic interventions may reduce the burden of this symptom warrants further investigation. Trial Registration ClinicalTrials.gov identifier: NCT02856074
Zitieren
APA
Baloch, R. M., & Béjot, Y. (2026). Prevalence and Determinants of Poststroke Fatigue in Patients Treated With Acute Revascularization Therapy. Acta Neurologica Scandinavica, 2026(1). https://doi.org/10.1155/ane/1432436
Vancouver
Baloch RM, Béjot Y. Prevalence and Determinants of Poststroke Fatigue in Patients Treated With Acute Revascularization Therapy. Acta Neurologica Scandinavica. 2026;2026(1). doi:10.1155/ane/1432436
BibTeX
@article{Baloch2026,
author = {Baloch, Ramen Munir and Béjot, Yannick},
title = {Prevalence and Determinants of Poststroke Fatigue in Patients Treated With Acute Revascularization Therapy},
journal = {Acta Neurologica Scandinavica},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/ane/1432436}
}
EUVIMED